Trans-Pacific Partnership Deal Undercuts Biologic Innovation
January 4, 2016
The United States and 11 other Pacific Rim countries recently signed the Trans-Pacific Partnership. Unfortunately, the final draft might not pass Congress, because of the deal's inadequate protection of intellectual property in biologic medicines.
Browse more articles on Health Issues